INSTITUTO NAC DE INVESTIGACIONES NUCLEARES has a total of 20 patent applications. It decreased the IP activity by 57.0%. Its first patent ever was published in 2010. It filed its patents most often in Mexico, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are ZIOPHARM ONCOLOGY INC, THERAPHARM GMBH and BLINKBIO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Mexico | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 | |
#7 | China | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Materials and metallurgy | |
#5 | Chemical engineering | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Santos Cuevas Clara Leticia | 10 |
#2 | Ferro Flores Guillermina | 10 |
#3 | Luna Gutiérrez Myrna Alejandra | 7 |
#4 | Jiménez Mancilla Nallely Patricia | 6 |
#5 | Azorín Vega Erika Patricia | 6 |
#6 | Ocampo García Blanca Eli | 5 |
#7 | Erika Patricia Azorín Vega | 5 |
#8 | Guillermina Ferro Flores | 5 |
#9 | Clara Leticia Santos Cuevas | 5 |
#10 | Nallely Patricia Jiménez Mancilla | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021080409A1 | Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo | |
MX2019003806A | Supercapacitor based on carbon nanostructures deposited on a separation membrane. | |
MX2018006507A | Reactor for punctual application of non-thermal plasma at atmospheric pressure. | |
MX2018003175A | 177lu-dota-hynic-ipsma as a therapeutic radiopharmaceutical targeting prostate-specific membrane antigen. | |
MX2017007346A | Telescopic elevation equipment for a meteorological station of a laboratory. | |
MX2016008466A | 99mtc-edda/hynic-ipsma as a radiopharmaceutical for detecting the overexpression of prostate-specific membrane antigen. | |
MX2010011281A | Method and device for treating diatomaceous earth waste and other waste in order to obtain construction materials. |